These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 19538007

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen.
    Lee JS, Paull K, Alvarez M, Hose C, Monks A, Grever M, Fojo AT, Bates SE.
    Mol Pharmacol; 1994 Oct; 46(4):627-38. PubMed ID: 7969041
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC, Liang YC, Klutz A, Hsu CI, Lin CF, Mold DE, Chou TC, Lee YC, Huang RC.
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
    [Abstract] [Full Text] [Related]

  • 5. Schisandrol A from Schisandra chinensis reverses P-glycoprotein-mediated multidrug resistance by affecting Pgp-substrate complexes.
    Fong WF, Wan CK, Zhu GY, Chattopadhyay A, Dey S, Zhao Z, Shen XL.
    Planta Med; 2007 Mar; 73(3):212-20. PubMed ID: 17318783
    [Abstract] [Full Text] [Related]

  • 6. Bryostatin 1 affects P-glycoprotein phosphorylation but not function in multidrug-resistant human breast cancer cells.
    Scala S, Dickstein B, Regis J, Szallasi Z, Blumberg PM, Bates SE.
    Clin Cancer Res; 1995 Dec; 1(12):1581-7. PubMed ID: 9815959
    [Abstract] [Full Text] [Related]

  • 7. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX, Yang XH.
    Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
    [Abstract] [Full Text] [Related]

  • 8. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH.
    Life Sci; 2008 Nov 21; 83(21-22):700-8. PubMed ID: 18845169
    [Abstract] [Full Text] [Related]

  • 9. Relationship of multidrug resistance to rhodamine-123 selectivity between carcinoma and normal epithelial cells: taxol and vinblastine modulate drug efflux.
    Brouty-Boyé D, Kolonias D, Wu CJ, Savaraj N, Lampidis TJ.
    Cancer Res; 1995 Apr 15; 55(8):1633-8. PubMed ID: 7712466
    [Abstract] [Full Text] [Related]

  • 10. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.
    Goren D, Horowitz AT, Tzemach D, Tarshish M, Zalipsky S, Gabizon A.
    Clin Cancer Res; 2000 May 15; 6(5):1949-57. PubMed ID: 10815920
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system.
    Wong HL, Bendayan R, Rauth AM, Xue HY, Babakhanian K, Wu XY.
    J Pharmacol Exp Ther; 2006 Jun 15; 317(3):1372-81. PubMed ID: 16547167
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Selection of antisense oligonucleotides for reversal of multidrug resistance in breast carcinoma cells.
    Gao P, Zhou GY, Lei DP, Zhang XF, Li L, Xu JW, Lin XY.
    Cytotherapy; 2007 Jun 15; 9(8):795-801. PubMed ID: 17917879
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells.
    Kobayashi T, Ishida T, Okada Y, Ise S, Harashima H, Kiwada H.
    Int J Pharm; 2007 Feb 01; 329(1-2):94-102. PubMed ID: 16997518
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Action of gossypol and rhodamine 123 on wild type and multidrug-resistant MCF-7 human breast cancer cells: 31P nuclear magnetic resonance and toxicity studies.
    Jaroszewski JW, Kaplan O, Cohen JS.
    Cancer Res; 1990 Nov 01; 50(21):6936-43. PubMed ID: 2208159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.